F. Hoffmann-La Roche Ltd, ABBOTT & Danaher are Dominating the Europe Diagnostic tests Market in 2019

Europe Diagnostic Tests Market is expected to grow with the CAGR of 8.7% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.

Access full Report @ https://www.databridgemarketresearch.com/reports/europe-diagnostic-tests-market

Europe diagnostic tests market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.    

The major players dealing in Europe diagnostic tests market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement into the market. This helped companies to maximize the sales with enhanced product portfolio. For instance,

• In July 2018, Abbott launched its first HIV viral load testing for patients use. This product m-PIMA HIV-1/2 VL helped the patients to check the results at home. This enhanced the product portfolio of the company and helped them to serve most of the rural areas of the world including Africa. This helped in fulfilling social responsibilities of the company and enhanced the rate of the company in terms of environmental, social & governance rate.  

F. Hoffmann-La Roche Ltd is dominating player in Europe diagnostic tests market. The other key players existing in the market includes ABBOTT, Danaher, BD, Thermo Fisher Scientific Inc., ACON Laboratories Inc., Hemosure, Inc., MicroGen Diagnostics, QIAGEN, Grifols, S.A, BODITECH MED INC., Chembio Diagnostic Systems, Inc., Nanoentek, DiaSorin S.p.A., Bio-Rad Laboratories, Inc., BIOMEDOMICS INC, EKF Diagnostics Holdings plc, Siemens Healthcare GmbH, and PerkinElmer Inc among others.

F. Hoffmann-La Roche Ltd

F. Hoffmann-La Roche Ltd is incorporated in 1896 and is headquartered in Basel, Switzerland. The company focuses on offering diagnostic products and they are also involved in the manufacturing and developing of the oncology, dermatology products including others.

For instance,

• In May 2020, F. Hoffmann-La Roche Ltd officially announced the acquisition of Stratos Genomics. This acquisition lead to the development of DNA based sequencing for diagnostics use. This enhanced the healthcare diagnosis segment of the company, thus leading to more revenue generation of the company.

The company has various subsidiaries around the globe Roche Holding Ltd (Switzerland), Chugai Pharmaceutical Co., Ltd. (Japan), Roche Algérie SPA (Algeria), mySugr GmbH (Austria) among others has global presence across North America, South America, Europe, Asia-Pacific, Middle East & Africa.

Abbott

Abbott was founded in 1888 and is headquartered in Illinois U.S. The company focuses on manufacturing, developing, discovering and selling a diversified and broad line of healthcare products including services. The company is dealing with the segments are established pharmaceutical products, nutritional products, diagnostics products, & medical devices and the market focused segment is diagnostics products. The product categories are healthcare professionals, consumers and the market focused category is healthcare professionals.

For instance,

• In July 2018, Abbott launched its first HIV viral load testing for patients use. This product m-PIMA HIV-1/2 VL helped the patients to check the results at home. This enhanced the product portfolio of the company and helped them to serve most of the rural areas of the world including Africa. This helped in fulfilling social responsibilities of the company and enhanced the rate of the company in terms of environmental, social & governance rate

The company has various subsidiaries around the globe are Abbott Administration Inc. (Delaware), Abbott Bioresearch Center, Inc. (Delaware), Abbott Cardiovascular Systems, Inc. (California), Abbott Diabetes Care Inc. (Delaware) among others and has global presence across North America, South America, Europe, Asia-Pacific, Middle East & Africa.

DANAHER

Danaher was founded in 1969 and is headquartered in Washington DC, USA. The company focuses on providing services which includes preclinical, translational, predictive models, biomarker delivery among others. The company is engaged in continuous development of diagnostic tests market. The products and business segments provided by the company are life sciences, diagnostics, environmental & applied solutions among which the diagnostics is market focused segment and product.

For instance,

• In April 2020, Leica Microsystems, a subsidiary of Danaher announced the launch of flagship platform for its new confocal microscopy which is known as STELLARIS. This platform allows to view the three dimensional view of the tissues and living cells.

The company has various subsidiaries around the globe are Hach (U.S.), Beckman Coulter (U.S.), Pall Corporation (U.S.), Integrated DNA Technologies (U.S.) among others. The company has wide presence across U.S., China, Germany and others.